0
Letters   |    
Acute Pisa Syndrome After Administration of a Single Dose of Donepezil
Ioannidis Panagiotis, M.D., Ph.D.; Maiovis Pantelis, M.D.; Balamoutsos George, M.D.; Karacostas Dimitris, M.D., Ph.D.
The Journal of Neuropsychiatry and Clinical Neurosciences 2012;24:E26-E26. 10.1176/appi.neuropsych.11070158
View Author and Article Information
Department of Neurology, AHEPA University Hospital, Thessaloniki, Greece

Department of Neurology, AHEPA University Hospital, Thessaloniki, Greece

Correspondence: Maiovis Pantelis, M.D.; e-mail: panmaio@hotmail.com

Extract

To the Editor: Tardive dystonia syndromes are well known complications of prolonged treatment with antipsychotic medications, especially the classic ones. Pisa syndrome, a sustained dystonia of the trunk and head to one side, is considered as an atypical form of tardive dystonia and sometimes can be acute.1 Several cases have also been reported in patients taking acetylcholinesterase inhibitors (ACEIs) for at least 1 month.2 We report a patient suffering from Alzheimer’s disease (AD) who presented with acute Pisa syndrome after administration of a single donepezil dose.

Figures in this Article

First Page Preview

View Large
First page PDF preview
Your Session has timed out. Please sign back in to continue.
Sign In Your Session has timed out. Please sign back in to continue.
Sign In to Access Full Content
 
Username
Password
Sign in via Athens (What is this?)
Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
Not a subscriber?

Subscribe Now/Learn More

PsychiatryOnline subscription options offer access to the DSM-IV-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

+

References

Suzuki  T;  Matsuzaka  H:  Drug-induced Pisa syndrome (pleurothotonus): epidemiology and management.  CNS Drugs   2002; 16:165–174
[CrossRef] | [PubMed]
 
Huvent-Grelle  D;  Roche  J;  Gaxatte  C  et al.:  [Relation between Pisa syndrome and choline esterase inhibitors in a cohort of Alzheimer’s disease patients].  Presse Med   2009; 38:150–153
[CrossRef] | [PubMed]
 
Kwak  YT;  Han  IW;  Baik  J  et al.:  Relation between cholinesterase inhibitor and Pisa syndrome.  Lancet   2000; 355:2222
[CrossRef] | [PubMed]
 
Vanacore  N;  Suzzareddu  G;  Maggini  M  et al.:  Pisa syndrome in a cohort of Alzheimer’s disease patients.  Acta Neurol Scand   2005; 111:199–201
[CrossRef] | [PubMed]
 
Villarejo  A;  Camacho  A;  García-Ramos  R  et al.:  Cholinergic-dopaminergic imbalance in Pisa syndrome.  Clin Neuropharmacol   2003; 26:119–121
[CrossRef] | [PubMed]
 
References Container
+
+

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Related Content
Books
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 12.  >
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 12.  >
What Your Patients Need to Know About Psychiatric Medications, 2nd Edition > Chapter 73.  >
APA Practice Guidelines > Chapter 16.  >
Topic Collections
Psychiatric News
Read more at Psychiatric News >>